Thousands of Risperdal Cases Previously Time-Barred, Reopened

In a 6 to 1 decision, the Pennsylvania Supreme Court opened the door for thousands of pending Risperdal injury cases to proceed to trial. The seven-justice court ruled that a jury must decide, on a case by case basis, at which date the plaintiff should have had knowledge that the ingestion of Janssen Pharmaceuticals drug […]

Sheller Gives Presentations on Risperdal and Opioid Litigation

Stephen A. Sheller, founder of Sheller PC, is often sought for his expertise in litigation against pharmaceutical manufacturers whose products cause harm to consumers. He recently has one of few private law firms chosen to work with the City of Philadelphia in opioid litigation. In October 2019 Sheller was an invited speaker at two conferences. October 12, 2019 “Big […]

$8 Billion Verdict: Jury decides J&J should pay in Risperdal case

October 9, 2019: Late yesterday a Philadelphia jury rendered an $8 billion punitive damages verdict against pharmaceutical company Johnson & Johnson for illegally marketing the antipsychotic drug Risperdal, putting young boys at risk for developing female-sized breast tissue. The condition, gynecomastia, is irreversible. “The conduct the jury saw in the courtroom was clear and convincing that J&J disregarded the […]

Positive Developments in Risperdal Litigation in August

scales,of,justice,law,firm,lawyer,lawsuit,sheller,attorney,national,case,class,action,mass,tort

Several positive developments this month for young men injured from taking the Risperdal. Risperdal is an anti-psychotic drug manufactured by Johnson & Johnson subsidiary Janssen Pharmaceuticals. The drug’s side effects included gynecomastia, the growth of female-like breast in young boys. $2.5M Jury Verdict Stands The Supreme Court of Pennsylvania has declined to hear an appeal of […]

Opioid Drugmakers May Be Liable Under Consumer Protection Laws

pharma

Philadelphia District Attorney Larry Krasner has been given approval by a state judge to move forward with with action against drugmakers and distributors for illegal marketing and sales of opioid painkillers resulting in a nationwide epidemic. The suit, a first of its kind, brings claims under Pennsylvania’s Unfair Trade Practices and Consumer Protection Law. The UTPCPL bans […]

Sheller on Thom Hartman Radio Show

From The Ring of Fire: Why Is Big Pharma Increasing Your Medicine Prices? By Thom Hartmann – July 17, 2019 The US pays more for medical drugs that in any country in the world. Health in the US is all about making a profit and drug prices have increased dramatically since Trump become president. Drug […]

New Trial for Risperdal Injury Previously Tossed

Risperdal,FDA,petition,sheller,approval,appeal,woodcock,janet

In another win for plaintiffs injured by Risperdal, a Pennsylvania appellate court reversed a trial courts decision to grant the defendants motion for nonsuit, mid-trial. This decision will send the case back to the Pennsylvania Courts of Common Pleas for retrial. In the 2016 case of T.M. vs Janssen Pharmaceuticals, the trial judge decided mid-trial […]

Oklahoma Sues J&J Over Opioid Crisis

Purdue Pharma is named the main defendant in multiple city, state and local lawsuits against the pharmaceutical companies that played a part in the current opioid crisis. The suits claim the drug maker’s aggressive marketing of its opioid painkiller OxyContin began the crisis more than two decades ago. News media has covered the crisis extensively, including John Oliver […]

Jury May Decide Risperdal Time Bar

Risperdal,FDA,petition,sheller,approval,appeal,woodcock,janet

Two cases in front of the Pennsylvania Supreme Court could result in 40% of the over 7,000 Risperdal cases being time barred from moving forward. The Pennsylvania docket for Risperdal cases has grown significantly in the last few years. The Pennsylvania Supreme Court is being asked to reconsider two lower court rulings that began the […]

Temple Law Honors Sheller with Doctor of Humane Letters

Attorney Stephen Sheller, founder of Sheller PC, was honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement Ceremony on May 16. The Beasley School of Law celebrates Stephen A. Sheller, founding and managing partner of Sheller, P.C. and a passionate advocate for underdog clients. His philanthropic support […]